0001193125-21-166762 | 10-K/A | XBRL Viewer | Thayer Ventures Acquisition Corp

Cover Page - USD ($)	5 Months Ended
Cover Page - USD ($)	Dec. 31, 2020	May 17, 2021	Jun. 30, 2020
Document Information [Line Items]
Document Type	10-K/A
Amendment Flag	true
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Document Annual Report	true
Document Transition Report	false
Entity Registrant Name	Thayer Ventures Acquisition Corp
Entity Central Index Key	0001820566
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity File Number	001-39791
Entity Tax Identification Number	85-2426959
Entity Address, Address Line One	25852 McBean Parkway
Entity Address, City or Town	Valencia
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91335
City Area Code	415
Local Phone Number	782-1414
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	TVAC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 0
ICFR Auditor Attestation Flag	false
Amendment Description	References throughout this Amendment No. 1 to Annual Report on Form 10-K (the “Amended Report”) to “we,” “us,” the “Company” or “our company” are to Thayer Ventures Acquisition Corporation, unless the context otherwise indicates. This Amended Report amends the Annual Report on Form 10-K of Thayer Ventures Acquisition Corporation for the period ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 24, 2021 (the “Original Report”). On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement titled Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”) (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed the view that certain warrants issued by SPACs may require classification as a liability of the entity measured at fair value, with changes in fair value recorded each period in earnings. The SEC Staff Statement discusses “certain features of warrants issued in SPAC transactions” that “may be common across many entities.” The SEC Staff Statement indicates that when one or more of such features is included in a warrant, the warrant “should be classified as a liability measured at fair value, with changes in fair value each period reported in earnings.” Since their issuance on December 15, 2020, our warrants have been accounted for as a component of stockholders’ equity within our balance sheet. After discussion and evaluation and taking into consideration the SEC Staff Statement, we have determined to classify our warrants as liabilities and will subsequently measure them at fair value pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”) in our financial statements. On May 11, 2021, the audit committee of the board of directors, after considering the recommendations of and in consultation with our management, concluded that our previously issued audited financial statements as of December 31, 2020 and for the period from July 31, 2020 (inception) through December 31, 2020 (the “Affected Period”) should be restated due to such change in classification of our warrants and should no longer be relied upon. Historically, our warrants were reflected as a component of equity as opposed to liabilities on the balance sheet and the statement of operations did not include the subsequent non-cash changes in estimated fair value of the warrants, based on our application of FASB ASC 815-40. The views expressed in the SEC Staff Statement were not consistent with our historical interpretation of the specific provisions within the warrants and our application of ASC 815-40 to the warrants. We reassessed our accounting for the warrants issued on December 15, 2020, in light of the SEC Staff’s published views. Based on this reassessment, we determined that the warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in our statement of operations each reporting period. The change in accounting for the warrants does not impact the amounts previously reported for our cash and cash equivalents, investments held in the trust account, operating expenses or total cash flows from operations for any period presented herein. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, we are hereby amending and restating in their entirety in this Amended Report, the following items: • Item 1A—Risk Factors; • Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations; • Item 8—Financial Statements and Supplementary Data; and • Item 9A—Controls and Procedures. In addition, we are also filing a signature page, and our Co-Chief Executive Officers and Chief Financial Officer have provided with this Amended Report new certifications dated as of the date of this filing (Exhibits 31.1, 31.2, 32.1 and 32.2). This Amended Report should be read in conjunction with the Original Report and with our filings with the SEC subsequent to the Original Report. We have not amended our prior Current Report on Form 8-K (File No. 001-39791) filed with the SEC on December 21, 2020, which contained our audited balance sheet as of December 15, 2020. The financial information contained in that Current Report on Form 8-K is superseded by the information in this Amended Report, and the financial statements and related financial information contained in such Current Report should no longer be relied upon. This Amended Report continues to describe the conditions as of the date of the Original Report and, except as expressly contained herein, we have not updated, modified or supplemented the disclosures contained in the Original Report. Accordingly, this Amended Report should be read in conjunction with the Original Report and with our filings with the SEC subsequent to the Original Report.
Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A common stock, $0.0001 par value
Trading Symbol	TVAC
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock
Trading Symbol	TVAC
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		17,250,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		4,312,500

Condensed Balance Sheet	Dec. 31, 2020 USD ($)
Current assets:
Cash	$ 1,242,226
Prepaid expenses	509,248
Total current assets	1,751,474
Investments held in Trust Account	175,950,325
Total Assets	177,701,799
Current liabilities:
Accounts payable	296,718
Accrued expenses	70,000
Franchise tax payable	83,836
Total current liabilities	450,554
Deferred underwriting commissions	6,900,000
Derivative warrant liabilities	15,871,750
Total Liabilities	23,222,304
Commitments and Contingencies
Class A common stock; 14,654,852 shares subject to possible redemption at $10.20 per share	149,479,490
Stockholders' Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	7,957,848
Accumulated deficit	(2,958,534)
Total stockholders' equity	5,000,005
Total Liabilities and Stockholders' Equity	177,701,799
Common Class A [Member]
Stockholders' Equity:
Common stock	260
Total stockholders' equity	260
Common Class B [Member]
Stockholders' Equity:
Common stock	431
Total stockholders' equity	$ 431

Condensed Balance Sheet (Parenthetical)	5 Months Ended
Condensed Balance Sheet (Parenthetical)	Dec. 31, 2020 $ / shares shares
Preferred stock, par value \| $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred Stock, Shares Issued	0
Preferred stock, shares outstanding	0
Common Class A [Member]
Common shares subject to redemption	14,654,852
Common stock redemption price per share \| $ / shares	$ 10.20
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	2,595,148
Common stock, shares outstanding	2,595,148
Common Class B [Member]
Common shares subject to redemption
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	4,312,500
Common stock, shares outstanding	4,312,500

Condensed Statement of Operations	5 Months Ended
Condensed Statement of Operations	Dec. 31, 2020 USD ($) $ / shares shares
General and administrative expenses	$ 108,674
Franchise tax expenses	83,836
Loss from operations	(192,510)
Interest and investment income	325
Financing costs - derivative warrant liabilities	(410,849)
Change in fair value of derivative warrant liabilities	(2,355,500)
Net loss	(2,958,534)
Common Class A [Member]
Net loss	$ 0
Weighted average shares outstanding \| shares	17,250,000
Basic and diluted net loss per share \| $ / shares
Common Class B [Member]
Net loss	$ 2,959,000
Weighted average shares outstanding \| shares	3,817,819
Basic and diluted net loss per share \| $ / shares	$ (0.77)

Condensed Statement of Changes in Stockholder's Deficit - 5 months ended Dec. 31, 2020 - USD ($)	Total	Common Class A [Member]	Common Class B [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Jul. 31, 2020
Balance (Shares) at Jul. 31, 2020		0	0
Issuance of common stock to sponsor	25,000		$ 431	24,569
Issuance of common stock to Sponsor (Shares)		0	4,312,500
Sale of units in initial public offering, less fair value of public warrants	165,082,500	$ 1,725		165,080,775
Sale of units in initial public offering, less fair value of public warrants [Shares]		17,250,000
Offering costs, net of reimbursement from underwriters	(8,745,721)			(8,745,721)
Excess of cash received over fair value of private placement warrants	1,076,250			1,076,250
Common stock subject to possible redemption	(149,479,490)	$ (1,465)		(149,478,025)
Common stock subject to possible redemption[Shares]		(14,654,852)
Net loss	(2,958,534)	$ 0	$ 2,959,000		(2,958,534)
Balance at Dec. 31, 2020	$ 5,000,005	$ 260	$ 431	$ 7,957,848	$ (2,958,534)
Balance (Shares) at Dec. 31, 2020		2,595,148	4,312,500

Consolidated Statements of Cash Flows	5 Months Ended
Consolidated Statements of Cash Flows	Dec. 31, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (2,958,534)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor under note payable	18,500
Income earned on investments held in Trust Account	(325)
Financing costs - derivative warrant liabilities	410,849
Change in fair value of derivative warrant liabilities	2,355,500
Changes in operating assets and liabilities:
Prepaid expenses	(509,248)
Accounts payable	61,811
Franchise tax payable	83,836
Net cash used in operating activities	(537,611)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(175,950,000)
Net cash used in investing activities	(175,950,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party	265,312
Repayment of note payable to related party	(400,000)
Proceeds received from initial public offering, gross	172,500,000
Proceeds received from private placement	7,175,000
Offering costs paid, net of reimbursement from underwriters	(1,810,475)
Net cash provided by financing activities	177,729,837
Net change in cash	1,242,226
Cash - beginning of the period
Cash - end of the period	1,242,226
Supplemental disclosure of noncash financing activities:
Offering costs paid in exchange for issuance of common stock to Sponsor	25,000
Offering costs included in accrued expenses	70,000
Offering costs included in accounts payable	234,907
Offering costs included in note payable	116,188
Deferred underwriting commissions in connection with the initial public offering	6,900,000
Initial value of Class A common stock subject to possible redemption	165,443,398
Change in value of Class A common stock subject to possible redemption	$ (15,963,908)

Description of Organization, Business Operations and Basis of Presentation

5 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Organization, Business Operations and Basis of Presentation

Note 1—Description of Organization, Business Operations and Basis of Presentation

Thayer Ventures Acquisition Corporation (the “Company”) is a blank check company incorporated in Delaware on July 31, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of December 31, 2020, the Company had not commenced any operations. All activity for the period from July 31, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (“the Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates

non-operating

income in the form of interest income on

investments made using

cash and cash equivalents from the proceeds derived from the Initial Public Offering.

The Company’s sponsor is Thayer Ventures Acquisition Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020, the Company consummated its Initial Public Offering of 17,250,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 2,250,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $172.5 million, and incurring offering costs of approximately $9.2 million, inclusive of $6.9 million in deferred underwriting commissions (Note 5) and net of reimbursement from underwriters of approximately $1.7 million.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,175,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.2 million (Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, approximately $176.0 million ($10.20 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions

under Rule 2a-7 under

the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the funds held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in Trust and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (currently at $10.20 per Public Share).

The per-share amount

to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” If the Company seeks stockholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in connection with a Business Combination in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all or are not a holder of record of Public Shares on the record date established in connection with a Business Combination. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

The Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The holders of the Founder Shares (the “initial stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem

100%

of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights

or pre-initial Business

Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering, or June 15, 2022, (the “Combination Period”) and the Company’s stockholders have not amended the Certificate of Incorporation to extend such Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at

a per-share price,

payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Basis of Presentation

The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC.

As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements as of December 31, 2020 and for the period from July 31, 2020 (inception) through December 31, 2020 (the “Affected Period”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited financial statements for such period. The restated financial statements are indicated as “Restated” in the audited financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Liquidity and Capital Resources

As of December 31, 2020, the Company had approximately $1.2 million outside of the Trust account and working capital of approximately $1.4 million, excluding approximately $0.1 million of franchise tax payable.

The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of Founders Shares (as defined in Note 4), and loan proceeds from the Sponsor of $400,000 under the Note (as defined Note 4). The Company repaid the Note in full on December 15, 2020. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Restatement of Previously Issued Financial Statements

5 Months Ended

Dec. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Restatement of Previously Issued Financial Statements

Note 2—Restatement of Previously Issued Financial Statements

In May 11, 2021, the Audit Committee of the Board of Directors, in consultation with management, concluded that, because of a misapplication of the accounting guidance related to its public and private placement warrants to purchase common stock that the Company issued in December 2020 (the “Warrants”), the Company’s previously issued financial statements for the Affected Period should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Period included in this Annual Report.

On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement titled “

Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)

(the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed the view that certain warrants issues by SPACs may require classification as a liability of the entity measured at fair value, with changes in fair value recorded each period in earnings. Since their issuance on December 15, 2020, the Company’s warrants have been accounted for as a component of stockholders’ equity within the Company’s previously reported balance sheet. After discussion and evaluation, including with the Company’s independent registered public accounting firm and the Company’s audit committee, management concluded that the warrants should be classified as liabilities and will subsequently measure them at fair value pursuant to ASC 815-40 in the Company’s financial statements.

Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheet and the statement of operations did not include the subsequent

non-cash

changes in estimated fair value of the Warrants, based on the Company’s application of ASC 815-40. The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within the warrants and the Company’s application of ASC

815-40

to the warrants. The Company reassessed its accounting for Warrants issued on December 15, 2020, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period.

Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued financial statements as of and for the period ended December 31, 2020 and as of December 15, 2020 (the “Affected Periods”) should be restated because of a misapplication in the guidance around accounting for certain of our outstanding warrants to purchase common stock (the “Warrants”) and should no longer be relied upon.

Impact of the Restatement

The impact of the restatement on the balance sheet, statement of operations and statement of cash flows for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities.


	As of December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	177,701,799		$	—		$	177,701,799

Liabilities and stockholders’ equity
Total current liabilities	$	450,554		$	—		$	450,554
Deferred underwriting commissions		6,900,000			—			6,900,000
Derivative warrant liabilities		—			15,871,750			15,871,750

Total liabilities		7,350,554			15,871,750			23,222,304
Class A common stock, $0.0001 par value; shares subject to possible redemption		165,351,241			(15,871,750	)		149,479,491
Stockholders’ equity
Preferred stock - $0.0001 par value		—			—			—
Class A common stock - $0.0001 par value		104			156			260
Class B common stock - $0.0001 par value		431			—			431
Additional paid-in-capital		5,191,654			2,766,194			7,957,848
Accumulated deficit		(192,185	)		(2,766,349	)		(2,958,534	)

Total stockholders’ equity		5,000,004			1			5,000,005

Total liabilities and stockholders’ equity	$	177,701,799		$	1		$	177,701,800


	Period From July 31, 2020 (Inception) Through December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Statement of Operations
Loss from operations	$	(192,510	)	$	—		$	(192,510	)
Other (expense) income:
Interest income on investments held in Trust Account		325			—			325
Financing costs - derivative warrant liabilities		—			(410,849	)		(410,849	)
Change in fair value of derivative warrant liabilities		—			(2,355,500	)		(2,355,500	)

Total other (expense) income		325			(2,766,349	)		(2,766,024	)

Net loss	$	(192,185	)	$	(2,766,349	)	$	(2,958,534	)

Basic and Diluted weighted-average Class A common shares outstanding		17,250,000			—			17,250,000

Basic and Diluted net income per Class A common share	$	—			—		$	—

Basic and Diluted weighted-average Class B common shares outstanding		3,817,819			—			3,817,819

Basic and Diluted net loss per Class B common share	$	(0.05	)	$	(0.72	)	$	(0.77	)


	Period From July 31, 2020 (Inception) Through December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Statement of Cash Flows
Net loss	$	(192,185	)	$	(2,766,349	)	$	(2,958,534	)
Adjustment to reconcile net loss to net cash used in operating activities		(345,426	)		—			(345,426	)
Change in fair value of derivative warrant liabilitie s		—			2,355,500			2,355,500
Financing costs - derivative warrant liabilities		—			410,849			410,849
Net cash used in operating activities		(537,611	)		—			(537,611	)
Net cash used in investing activities		(175,950,000	)		—			(175,950,000	)
Net cash provided by financing activities		177,729,837			—			177,729,837

Net change in cash	$	1,242,226		$	—		$	1,242,226


	As of December 15, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	178,262,938		$	—		$	178,262,938

Liabilities and stockholders’ equity
Total current liabilities	$	919,531		$	—		$	919,531
Deferred underwriting commissions		6,900,000			—			6,900,000
Derivative warrant liabilities		—			13,516,250			13,516,250

Total liabilities		7,819,531			13,516,250			21,335,781
Class A common stock, $0.0001 par value; shares subject to possible redemption		165,443,398			(13,516,250	)		151,927,148
Stockholders’ equity
Preferred stock - $0.0001 par value		—			—			—
Class A common stock - $0.0001 par value		103			132			235
Class B common stock - $0.0001 par value		431			—			431
Additional paid-in-capital		5,099,498			410,717			5,510,215
Accumulated deficit		(100,023	)		(410,849	)		(510,872	)

Total stockholders’ equity		5,000,009			—			5,000,009

Total liabilities and stockholders’ equity	$	178,262,938		$	—		$	178,262,938

Summary of Significant Accounting Policies

5 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note

—Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000 and investments held in Trust Account. As of December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. The Company’s investments held in the Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. Treasury securities, or a combination thereof.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2020, there were no cash equivalents in the Company’s operating cash account.

Investments held in Trust Account

The Company’s portfolio of investments held in trust is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these investments are included in net gain from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable, accrued expenses, and franchise taxes payable approximate their fair values primarily due to the short-term nature of the instruments.

The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets, other than for investments in open-ended money, in which case the Company uses NAV as a practical expedient to fair value.

Derivative warrant liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC

815-15.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is

re-assessed

at the end of each reporting period. In accordance with ASC

825-10

“Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.

The 8,625,000

issued in connection with the Initial Public Offering (the “Public Warrants”) and the

7,175,000

Private Placement Warrants are recognized as derivative liabilities in accordance with ASC

815-40.

Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to

re-measurement

at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering have been measured at fair value using a Monte Carlo simulation model. The fair value of the warrants issued in the Private Placement were estimated using Black-Scholes.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, and underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Of the total offering costs of the Initial Public Offering, approximately $0.4 million is included in financing cost -derivative warrant liabilities in the statement of operations and $8.7 million is included in stockholders’ equity.

Class A Common Stock Subject to Possible Redemption

Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2020, 14,654,852 shares of Class A common stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

Net Income (Loss) Per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 15,800,000 shares of Class A common stock in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted earnings per common share is the same as basic earnings per common share for the period presented.

The Company’s statement of operations includes a presentation of income (loss) per share for common stock subject to redemption in a manner similar to the

two-class

method of income per share. Net income (loss) per common stock, basic and diluted for Class A common stock is calculated by dividing the income on investments held in the Trust Account of approximately

$325

, net of applicable income and franchise taxes of approximately

$325

for the period from July 31, 2020 (inception) to December 31, 2020, by the weighted average number of shares of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock for the period from July 31, 2020 (inception) through December 31, 2020 is calculated by dividing the net loss of

$2,959,000

, less net income attributable to Class A common stock of

, resulting in a net loss of $

2,959,000

, by the weighted average number of Class B common stock outstanding for the period.

Income Taxes

Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

5 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Initial Public Offering

Note

—Initial Public Offering

On December 15, 2020, the Company consummated its Initial Public Offering of 17,250,000 Units, including 2,250,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $172.5 million, and incurring offering costs of approximately $9.2 million, inclusive of $6.9 million in deferred underwriting commissions and net of reimbursement from underwriters of approximately $1.7 million. Of the 17,250,000 Units sold, 4,944,550 Units were purchased by three qualified institutional buyers not affiliated with the Sponsor or any member of the management team (the “Anchor Investors”).

Each Unit consists of one share of Class A common stock,

and one-half of

one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 6).

Related Party Transactions

5 Months Ended

Dec. 31, 2020

Related Party Transactions

Note

—Related Party Transactions

Founder Shares and Private Placement Shares

On August 11, 2020, the Sponsor subscribed to purchase 5,031,250 shares of the Company’s Class B common stock, par value $0.0001 per share (the “Founder Shares”) for an aggregate price of $25,000. On August 13, 2020, the Sponsor paid $25,000 for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares. On October 27, 2020, 718,750 Founder Shares were contributed back to the Company for no consideration, resulting in an aggregate of 4,312,500 Founder Shares issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender. On November 9, 2020, the Sponsor transferred 25,000 Founder Shares to each of the independent director nominees. The initial stockholders agreed to forfeit up to 562,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriter exercised its over-allotment option in full on December 15, 2020; thus, these 562,500 Founder Shares were no longer subject to forfeiture.

The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the shares of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within

any 30-trading day

period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 7,175,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.2 million.

Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will

be non-redeemable for

cash and exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees.

The purchasers of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination.

Related Party Loans

On August 11, 2020, the Sponsor agreed to loan the Company an aggregate of up to $400,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan

is non-interest bearing

and payable on the earlier of the completion of the Initial Public Offering or the date the Company determines not to conduct an Initial Public Offering. The Company borrowed $400,000 under the Note. On December 15, 2020, the Company repaid the Note in full.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2020, the Company had no borrowings under the Working Capital Loans.

Administrative Support Agreement

Commencing on the date of the final prospectus of the Initial Public Offering and continuing until the earlier of the Company’s consummation of a Business Combination and the Company’s liquidation, the Company will pay the Sponsor a total of $20,000 per month for office space and administrative and support services. No charges were incurred as of December 31, 2020.

The Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for

any out-of-pocket expenses

incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company’s audit committee will review, on a quarterly basis, all payments that were made to the Sponsor, executive officers or directors, or the Company or their affiliates.

Commitments and Contingencies

5 Months Ended

Dec. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note

—Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. However, the registration and stockholder rights agreement will provide that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable

lock-up

period.

Underwriting Agreement

The underwriters were entitled to an underwriting discount of $0.20 per Unit, or approximately $3.45 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.40 per Unit, or $6.9 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

The underwriters also made a payment to the Company in an amount equal to 1.0% of the gross proceeds of the Initial Public Offering, or approximately $1.7 million in the aggregate to reimburse certain of the Company’s expenses.

Deferred Consulting Fees

In September 2020, the Company entered into an engagement letter with a consultant to obtain advisory services in connection with its search for a business combination target, pursuant to which the Company agreed to pay a $10,000 initial fee upon execution and a deferred success fee of $50,000 upon the consummation of the Initial Business Combination.

Risks and Uncertainties

Management continues to evaluate the impact of the

COVID-19

global pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Derivative Warrant Liabilities

5 Months Ended

Dec. 31, 2020

Derivative Warrant Liabilities [Abstract]

Derivative Warrant Liabilities

Note 7—Derivative Warrant Liabilities

As of December 31, 2020, the Company has 8,625,000 and 7,175,000 Public Warrants and Private Placement Warrants, respectively, outstanding.

Public Warrants may only be exercised for a whole number of shares.

No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60

business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Company’s initial stockholders or their affiliates, without taking into account any Founder Shares held by the Company’s initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will

be non-redeemable so

long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $18.00:

Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption; and

•

if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) for any 20 trading days within

a 30-trading day

period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).

The Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout

the 30-day redemption

period.

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $10.00:

After the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock determined by reference to an agreed table based on the redemption date and the “fair market value” of the shares of Class A common stock (as defined below); provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share;

•

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and

•

if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) then the Private Placement Warrants must also concurrently be called for redemption on the same terms (equal to a number of shares of Class A common stock) as the outstanding Public Warrants as described above.

The “fair market value” of Class A common stock for the above purpose shall mean the average reported last sale price of Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment).

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Stockholder's Equity

5 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Stockholder's Equity

Note 8—Stockholders’ Equity

Preferred Stock

– The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2020, there were no preferred shares outstanding.

Class

Common Stock

— The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2020, there were 17,250,000 shares of Class A common stock outstanding, including 16,210,906 shares of Class A common stock subject to possible conversion that were classified as temporary equity in the accompanying balance sheet.

Class

Common Stock

— The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of December 31, 2020, there were 4,312,500 shares of Class B common stock issued and outstanding.

Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. With respect to any matter submitted to a vote of the stockholders, including any vote in connection with the initial Business Combination, except as required by law or the applicable rules of Nasdaq then in effect, holders of the shares of Class A common stock and shares of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders.

The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination on

a one-for-one basis

(subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of the Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the initial stockholders agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on

an as-converted basis,

20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the Business Combination (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders) (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. In no event will the shares of the Company’s Class B common stock convert into shares of the Company’s Class A common stock at a rate of less

than one-to-one.

Fair Value Measurements

5 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 9—Fair Value Measurements

The following table presents information about the Company’s financial

assets and liabilities

that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy:


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Investments held in Trust Account	$	172,500,000	$	—	$	—
Liabilities:
Derivative warrant liabilities	$	—	$	—	$	15,871,750

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were

transfers between levels for the period from July 31, 2020 (inception) through December 31, 2020.

Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Level 3 instruments are comprised of derivative warrant liabilities measured at fair value using a Monte Carlo simulation model and Black-Scholes.

The fair value of the Public Warrants issued in connection with the Public Offering have been measured at fair value using a Monte Carlo simulation model. The fair value of the warrants issued in the Private Placement were estimated using Black-Scholes.

The estimated fair value of the Private Placement Warrants and the Public Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo simulation and Black-Scholes are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	As of December 15, 2020			As of December 31, 2020
	Public and Private			Public and Private
Exercise pric e	$	11.50		$	11.50
Volatility		15.0	%		15.0	%
Stock price	$	9.57		$	9.98
Expected life of t he options to convert		6.54			6.5
Risk-free rate		0.58	%		0.58	%
Dividend yield		0.0	%		0.0	%

The change in the fair value of the derivative warrant liabilities for the period ended December 31, 2020 is summarized as follows:


Derivative warrant liabilities at July 31, 2020 (inception)	$	—
Issuance of Public and Private Warrants		13,516,250
Change in fair value of derivative warrant liabilities		2,355,500

Derivative warrant liabilities at December 31, 2020	$	15,871,750

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes

5 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Note

—Income Taxes

The Company’s taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative expenses are generally considered

start-up

costs and are not currently deductible. There was no income tax expense for the period from July 31, 2020 (inception) through December 31, 2020.

The income tax provision (benefit) consists of the following:


	December 31, 2020
Current
Federal	$	—
State		—
Deferred
Federal		(40,359	)
State		—
Valuation allowance		40,359

Income tax provision	$	—

The Company’s net deferred tax assets are as follows:


	December 31, 2020
Deferred tax assets:
Net operating loss carryover	$	17,537
Start-up/Organization costs		22,822

Total deferred tax assets		40,359
Valuation allowance		(40,359	)

Deferred tax asset, net of allowance	$	—

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance.

There were no unrecognized tax benefits as of December 31, 2020. No amounts were accrued for the payment of interest and penalties at December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows:


	December 31, 2020
Statutory Federal income tax rate		21.0	%
Financing cost - derivative warrant liabilities		(16.72 )	%
Change in fair value of derivative warrant liabilities		(2.92 )	%
Change in Valuation Allowance		(1.4	)%

Income Taxes Benefit		0.0	%

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Subsequent Events

5 Months Ended

Dec. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

Note

—Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Other than as described herein, including in Note 2 — Restatement of Previously Issued Financial Statements, based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accounting Policies (Policies)

5 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Use of Estimates

Concentration of Credit Risk

Cash and Cash Equivalents

Investments held in Trust Account

Financial Instruments

•

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

•

Derivative warrant liabilities

815-15.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is

re-assessed

at the end of each reporting period. In accordance with ASC

825-10

The 8,625,000

issued in connection with the Initial Public Offering (the “Public Warrants”) and the

7,175,000

Private Placement Warrants are recognized as derivative liabilities in accordance with ASC

815-40.

Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to

re-measurement

Offering Costs Associated with the Initial Public Offering

Class A Common Stock Subject to Possible Redemption

Net Income (Loss) Per Common Stock

The Company’s statement of operations includes a presentation of income (loss) per share for common stock subject to redemption in a manner similar to the

two-class

$325

, net of applicable income and franchise taxes of approximately

$325

$2,959,000

, less net income attributable to Class A common stock of

, resulting in a net loss of $

2,959,000

, by the weighted average number of Class B common stock outstanding for the period.

Income Taxes

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Issued Financial Statements (Tables)

5 Months Ended

Dec. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Summary of restatement of balance sheet, statement of operations and cash flow statement


	As of December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	177,701,799		$	—		$	177,701,799

Liabilities and stockholders’ equity
Total current liabilities	$	450,554		$	—		$	450,554
Deferred underwriting commissions		6,900,000			—			6,900,000
Derivative warrant liabilities		—			15,871,750			15,871,750

Total liabilities		7,350,554			15,871,750			23,222,304
Class A common stock, $0.0001 par value; shares subject to possible redemption		165,351,241			(15,871,750	)		149,479,491
Stockholders’ equity
Preferred stock - $0.0001 par value		—			—			—
Class A common stock - $0.0001 par value		104			156			260
Class B common stock - $0.0001 par value		431			—			431
Additional paid-in-capital		5,191,654			2,766,194			7,957,848
Accumulated deficit		(192,185	)		(2,766,349	)		(2,958,534	)

Total stockholders’ equity		5,000,004			1			5,000,005

Total liabilities and stockholders’ equity	$	177,701,799		$	1		$	177,701,800


	Period From July 31, 2020 (Inception) Through December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Statement of Operations
Loss from operations	$	(192,510	)	$	—		$	(192,510	)
Other (expense) income:
Interest income on investments held in Trust Account		325			—			325
Financing costs - derivative warrant liabilities		—			(410,849	)		(410,849	)
Change in fair value of derivative warrant liabilities		—			(2,355,500	)		(2,355,500	)

Total other (expense) income		325			(2,766,349	)		(2,766,024	)

Net loss	$	(192,185	)	$	(2,766,349	)	$	(2,958,534	)

Basic and Diluted weighted-average Class A common shares outstanding		17,250,000			—			17,250,000

Basic and Diluted net income per Class A common share	$	—			—		$	—

Basic and Diluted weighted-average Class B common shares outstanding		3,817,819			—			3,817,819

Basic and Diluted net loss per Class B common share	$	(0.05	)	$	(0.72	)	$	(0.77	)


	Period From July 31, 2020 (Inception) Through December 31, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Statement of Cash Flows
Net loss	$	(192,185	)	$	(2,766,349	)	$	(2,958,534	)
Adjustment to reconcile net loss to net cash used in operating activities		(345,426	)		—			(345,426	)
Change in fair value of derivative warrant liabilitie s		—			2,355,500			2,355,500
Financing costs - derivative warrant liabilities		—			410,849			410,849
Net cash used in operating activities		(537,611	)		—			(537,611	)
Net cash used in investing activities		(175,950,000	)		—			(175,950,000	)
Net cash provided by financing activities		177,729,837			—			177,729,837

Net change in cash	$	1,242,226		$	—		$	1,242,226


	As of December 15, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	178,262,938		$	—		$	178,262,938

Liabilities and stockholders’ equity
Total current liabilities	$	919,531		$	—		$	919,531
Deferred underwriting commissions		6,900,000			—			6,900,000
Derivative warrant liabilities		—			13,516,250			13,516,250

Total liabilities		7,819,531			13,516,250			21,335,781
Class A common stock, $0.0001 par value; shares subject to possible redemption		165,443,398			(13,516,250	)		151,927,148
Stockholders’ equity
Preferred stock - $0.0001 par value		—			—			—
Class A common stock - $0.0001 par value		103			132			235
Class B common stock - $0.0001 par value		431			—			431
Additional paid-in-capital		5,099,498			410,717			5,510,215
Accumulated deficit		(100,023	)		(410,849	)		(510,872	)

Total stockholders’ equity		5,000,009			—			5,000,009

Total liabilities and stockholders’ equity	$	178,262,938		$	—		$	178,262,938

Fair Value Measurements (Tables)

5 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Summary of fair value, measured on recurring basis

The following table presents information about the Company’s financial

assets and liabilities

that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy:


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Investments held in Trust Account	$	172,500,000	$	—	$	—
Liabilities:
Derivative warrant liabilities	$	—	$	—	$	15,871,750

Summary of quantitative information regarding fair value measurements

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	As of December 15, 2020			As of December 31, 2020
	Public and Private			Public and Private
Exercise pric e	$	11.50		$	11.50
Volatility		15.0	%		15.0	%
Stock price	$	9.57		$	9.98
Expected life of t he options to convert		6.54			6.5
Risk-free rate		0.58	%		0.58	%
Dividend yield		0.0	%		0.0	%

Summary of change in derivative warrant liabilities measured at fair value

The change in the fair value of the derivative warrant liabilities for the period ended December 31, 2020 is summarized as follows:


Derivative warrant liabilities at July 31, 2020 (inception)	$	—
Issuance of Public and Private Warrants		13,516,250
Change in fair value of derivative warrant liabilities		2,355,500

Derivative warrant liabilities at December 31, 2020	$	15,871,750

Income Taxes (Tables)

5 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Schedule of components of income tax expense (benefit)

The income tax provision (benefit) consists of the following:


	December 31, 2020
Current
Federal	$	—
State		—
Deferred
Federal		(40,359	)
State		—
Valuation allowance		40,359

Income tax provision	$	—

Schedule of deferred tax assets and liabilities

The Company’s net deferred tax assets are as follows:


	December 31, 2020
Deferred tax assets:
Net operating loss carryover	$	17,537
Start-up/Organization costs		22,822

Total deferred tax assets		40,359
Valuation allowance		(40,359	)

Deferred tax asset, net of allowance	$	—

Schedule of effective income tax rate reconciliation

A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows:


	December 31, 2020
Statutory Federal income tax rate		21.0	%
Financing cost - derivative warrant liabilities		(16.72 )	%
Change in fair value of derivative warrant liabilities		(2.92 )	%
Change in Valuation Allowance		(1.4	)%

Income Taxes Benefit		0.0	%

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail) - USD ($)		5 Months Ended
	Dec. 15, 2020	Dec. 31, 2020	Aug. 11, 2020
Shares issued during period new issues	17,250,000
Share price	$ 10.20
Proceeds from initial public offering	$ 172,500,000	$ 172,500,000
Proceeds from issuance of common stock	$ 176,000,000
Investment maturity period	185 days
Share redemption price per share		$ 10.20
Cash		$ 1,242,226
Working capital deficit		1,400,000
Issuance of common stock to sponsor		$ 25,000
Offering costs	$ 9,200,000
Threshold percentage on fair market value of net assets held In trust account for business combination		80.00%
Threshold percentage on purchase of outstanding voting shares for business combination		50.00%
Net tangible assets required for business combination		$ 5,000,001
Threshold number of days allowed to consummate business combination		18 months
Minimum interest on trust deposits eligible to pay dissolution expenses		$ 100,000
Deferred underwriting expense	6,900,000
Underwriting commission reimbursement	$ 1,700,000
Franchise tax payable		83,836
Private Placement Warrant [Member]
Warrants issued during the period	7,175,000
Warrants issued price per warrant	$ 1.00
Proceeds from issuance of warrants	$ 7,200,000
Sponsor [Member]
Issuance of common stock to sponsor		$ 25,000
Debt face amount			$ 400,000
IPO [Member]
Shares issued during period new issues	17,250,000
Share price	$ 10.00
Maximum percentage of shares redeemed without prior consent from company		15.00%
Maximum percentage of shares redeemed on non completion of business combination		100.00%
Over-Allotment Option [Member]
Shares issued during period new issues	2,250,000

Restatement of Previously Issued Financial Statements - Summary of Restatement of Balance Sheet ,Statement of Operations and Cash Flow Statement (Detail) - USD ($)	5 Months Ended
	Dec. 31, 2020	Dec. 15, 2020	Jul. 31, 2020
Balance Sheet
Total Assets	$ 177,701,799
Liabilities and stockholders' equity
Total current liabilities	450,554
Deferred underwriting commissions	6,900,000
Derivative warrant liabilities	15,871,750
Total Liabilities	23,222,304
Class A common stock, $0.0001 par value; shares subject to possible redemption	149,479,490
Stockholders' equity:
Preferred stock - $0.0001 par value
Additional paid-in capital	7,957,848
Accumulated deficit	(2,958,534)
Total stockholders' equity	5,000,005
Total Liabilities and Stockholders' Equity	177,701,799
Statement of Operations
Loss from operations	(192,510)
Other (expense) income:
Interest income on investments held in Trust Account	325
Financing costs - derivative warrant liabilities	(410,849)
Change in fair value of derivative warrant liabilities	(2,355,500)
Net loss	(2,958,534)
Statement of Cash Flows
Net loss	(2,958,534)
Change in fair value of derivative warrant liabilities	2,355,500
Financing costs - derivative warrant liabilities	410,849
Net cash used in operating activities	(537,611)
Net cash used in investing activities	(175,950,000)
Net cash provided by financing activities	177,729,837
Net change in cash	1,242,226
Common Class A [Member]
Stockholders' equity:
Common stock	260
Total stockholders' equity	260
Other (expense) income:
Net loss	$ 0
Weighted average shares outstanding	17,250,000
Basic and diluted net loss per share
Statement of Cash Flows
Net loss	$ 0
Common Class B [Member]
Stockholders' equity:
Common stock	431
Total stockholders' equity	431
Other (expense) income:
Net loss	$ 2,959,000
Weighted average shares outstanding	3,817,819
Basic and diluted net loss per share	$ (0.77)
Statement of Cash Flows
Net loss	$ 2,959,000
Previously Reported [Member]
Balance Sheet
Total Assets	177,701,799	$ 178,262,938
Liabilities and stockholders' equity
Total current liabilities	450,554	919,531
Deferred underwriting commissions	6,900,000	6,900,000
Derivative warrant liabilities	0	0
Total Liabilities	7,350,554	7,819,531
Class A common stock, $0.0001 par value; shares subject to possible redemption	165,351,241	165,443,398
Stockholders' equity:
Preferred stock - $0.0001 par value	0	0
Additional paid-in capital	5,191,654	5,099,498
Accumulated deficit	(192,185)	(100,023)
Total stockholders' equity	5,000,004	5,000,009
Total Liabilities and Stockholders' Equity	177,701,799	178,262,938
Statement of Operations
Loss from operations	(192,510)
Other (expense) income:
Interest income on investments held in Trust Account	325
Financing costs - derivative warrant liabilities	0
Change in fair value of derivative warrant liabilities	0
Total other (expense) income	325
Net loss	(192,185)
Statement of Cash Flows
Net loss	(192,185)
Adjustment to reconcile net loss to net cash used in operating activities	(345,426)
Change in fair value of derivative warrant liabilities	0
Financing costs - derivative warrant liabilities	0
Net cash used in operating activities	(537,611)
Net cash used in investing activities	(175,950,000)
Net cash provided by financing activities	177,729,837
Net change in cash	1,242,226
Previously Reported [Member] \| Common Class A [Member]
Stockholders' equity:
Common stock	$ 104	103
Other (expense) income:
Weighted average shares outstanding	17,250,000
Basic and diluted net loss per share	$ 0
Previously Reported [Member] \| Common Class B [Member]
Stockholders' equity:
Common stock	$ 431	431
Other (expense) income:
Weighted average shares outstanding	3,817,819
Basic and diluted net loss per share	$ (0.05)
Revision of Prior Period, Reclassification, Adjustment [Member]
Balance Sheet
Total Assets	$ 0	0
Liabilities and stockholders' equity
Total current liabilities	0	0
Deferred underwriting commissions	0	0
Derivative warrant liabilities	15,871,750	13,516,250
Total Liabilities	15,871,750	13,516,250
Class A common stock, $0.0001 par value; shares subject to possible redemption	(15,871,750)	(13,516,250)
Stockholders' equity:
Preferred stock - $0.0001 par value	0	0
Additional paid-in capital	2,766,194	410,717
Accumulated deficit	(2,766,349)	(410,849)
Total stockholders' equity	1	0
Total Liabilities and Stockholders' Equity	1	0
Statement of Operations
Loss from operations	0
Other (expense) income:
Interest income on investments held in Trust Account	0
Financing costs - derivative warrant liabilities	(410,849)
Change in fair value of derivative warrant liabilities	(2,355,500)
Total other (expense) income	(2,766,349)
Net loss	(2,766,349)
Statement of Cash Flows
Net loss	(2,766,349)
Adjustment to reconcile net loss to net cash used in operating activities	0
Change in fair value of derivative warrant liabilities	2,355,500
Financing costs - derivative warrant liabilities	410,849
Net cash used in operating activities	0
Net cash used in investing activities	0
Net cash provided by financing activities	0
Net change in cash	0
Revision of Prior Period, Reclassification, Adjustment [Member] \| Common Class A [Member]
Stockholders' equity:
Common stock	$ 156	132
Other (expense) income:
Weighted average shares outstanding	0
Basic and diluted net loss per share	$ 0
Revision of Prior Period, Reclassification, Adjustment [Member] \| Common Class B [Member]
Stockholders' equity:
Common stock	$ 0	0
Other (expense) income:
Weighted average shares outstanding	0
Basic and diluted net loss per share	$ (0.72)
Restated [Member]
Balance Sheet
Total Assets	$ 177,701,799	178,262,938
Liabilities and stockholders' equity
Total current liabilities	450,554	919,531
Deferred underwriting commissions	6,900,000	6,900,000
Derivative warrant liabilities	15,871,750	13,516,250
Total Liabilities	23,222,304	21,335,781
Class A common stock, $0.0001 par value; shares subject to possible redemption	149,479,491	151,927,148
Stockholders' equity:
Preferred stock - $0.0001 par value	0	0
Additional paid-in capital	7,957,848	5,510,215
Accumulated deficit	(2,958,534)	(510,872)
Total stockholders' equity	5,000,005	5,000,009
Total Liabilities and Stockholders' Equity	177,701,800	178,262,938
Statement of Operations
Loss from operations	(192,510)
Other (expense) income:
Interest income on investments held in Trust Account	325
Financing costs - derivative warrant liabilities	(410,849)
Change in fair value of derivative warrant liabilities	(2,355,500)
Total other (expense) income	(2,766,024)
Net loss	(2,958,534)
Statement of Cash Flows
Net loss	(2,958,534)
Adjustment to reconcile net loss to net cash used in operating activities	(345,426)
Change in fair value of derivative warrant liabilities	2,355,500
Financing costs - derivative warrant liabilities	410,849
Net cash used in operating activities	(537,611)
Net cash used in investing activities	(175,950,000)
Net cash provided by financing activities	177,729,837
Net change in cash	1,242,226
Restated [Member] \| Common Class A [Member]
Stockholders' equity:
Common stock	$ 260	235
Other (expense) income:
Weighted average shares outstanding	17,250,000
Basic and diluted net loss per share	$ 0
Restated [Member] \| Common Class B [Member]
Stockholders' equity:
Common stock	$ 431	$ 431
Other (expense) income:
Weighted average shares outstanding	3,817,819
Basic and diluted net loss per share	$ (0.77)

Restatement of Previously Issued Financial Statements - Summary of Restatement of Balance Sheet ,Statement of Operations and Cash Flow Statement (Parenthetical) (Detail) - $ / shares	Dec. 31, 2020	Dec. 15, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Preferred stock, par value	$ 0.0001	$ 0.0001
Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, par value	0.0001	0.0001
Temporary equity, par or stated value per share	0.0001	0.0001
Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, par value	$ 0.0001	$ 0.0001

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	5 Months Ended
	Dec. 31, 2020	Jul. 31, 2020
Federal deposit insurance corporation coverage limit	$ 250,000
Unrecognized tax benefits	0
Income tax penalties and interest accrued	$ 0
Potentially dilutive common shares excluded from the computation of weighted-average shares outstanding	15,800,000
Investment income earned on the Trust Account	$ 325
Franchise Tax Income	325
Net income loss	(2,958,534)
Financing costs - derivative warrant liabilities	410,849
Stockholders' equity	$ 5,000,005
Common Class A [Member]
Common shares subject to redemption	14,654,852
Net income loss	$ 0
Stockholders' equity	$ 260
Common Class B [Member]
Common shares subject to redemption
Net income loss	$ 2,959,000
Stockholders' equity	431
IPO [Member]
Financing costs - derivative warrant liabilities	400,000
Stockholders' equity	$ 8,700,000
IPO [Member] \| Public Warrants [Member]
Class of warrant or right,issued during the period	8,625,000
IPO [Member] \| Private Placement Warrants [Member]
Class of warrant or right,issued during the period	7,175,000

Initial Public Offering - Additional Information (Detail) - USD ($)		5 Months Ended
	Dec. 15, 2020	Dec. 31, 2020
Shares issued during period new issues	17,250,000
Share price	$ 10.20
Proceeds from initial public offering	$ 172,500,000	$ 172,500,000
Offering costs	9,200,000
Deferred underwriting expense	6,900,000
Underwriting commission reimbursement	$ 1,700,000
Public Warrant [Member]
Description of class of warrant or right	Each Unit consists of one share of Class A common stock, and one-half of one redeemable warrant
Exercise price of warrants	$ 11.50
Anchor Investors [Member]
Shares issued during period new issues	4,944,550
IPO [Member]
Shares issued during period new issues	17,250,000
Share price	$ 10.00
Over-Allotment Option [Member]
Shares issued during period new issues	2,250,000
Common Class A [Member]
Shares issued during period new issues		17,250,000
Number of securities called by each warrant	1

Related Party Transactions - Additional Information (Detail) - USD ($)					5 Months Ended
	Dec. 31, 2020	Dec. 15, 2020	Aug. 13, 2020	Aug. 11, 2020	Dec. 31, 2020	Oct. 27, 2020
Related Party Transaction [Line Items]
Share price		$ 10.20
Issuance of common stock to sponsor					$ 25,000
Working Capital Loans [Member]
Related Party Transaction [Line Items]
Debt face amount	$ 1,500,000				$ 1,500,000
Debt instrument, convertible conversion price	$ 1.00				$ 1.00
Notes payable, related parties	$ 20,000				$ 20,000
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock, shares issued	4,312,500				4,312,500
Common stock, shares outstanding	4,312,500				4,312,500
Common stock, par value	$ 0.0001	0.0001			$ 0.0001
Issuance of common stock to sponsor					$ 431
Common Class A [Member]
Related Party Transaction [Line Items]
Common stock, shares issued	2,595,148				2,595,148
Common stock, shares outstanding	2,595,148				2,595,148
Common stock, par value	$ 0.0001	$ 0.0001			$ 0.0001
Issuance of common stock to sponsor
Sponsor [Member]
Related Party Transaction [Line Items]
Debt face amount				$ 400,000
Issuance of common stock to sponsor					$ 25,000
Sponsor [Member] \| Shares Subject to Forfeiture [Member]
Related Party Transaction [Line Items]
Common stock, shares outstanding		562,500
Sponsor [Member] \| Founder Shares [Member]
Related Party Transaction [Line Items]
Common stock, shares issued						4,312,500
Common stock, shares outstanding		562,500				4,312,500
Shares surrendered during the period						718,750
Percentage of founder shares to common stock outstanding after IPO		20.00%
Sponsor [Member] \| Founder Shares [Member] \| Independent Director [Member]
Related Party Transaction [Line Items]
Shares transferred during the period		25,000
Sponsor [Member] \| Related Party Loans [Member]
Related Party Transaction [Line Items]
Debt face amount				$ 400,000
Proceeds from related party debt	$ 400,000
Sponsor [Member] \| Private Placement [Member]
Related Party Transaction [Line Items]
Warrants issued during the period		7,175,000
Warrants issued price per warrant		$ 1.00
Proceeds from issuance of warrants		$ 7,200,000
Exercise price of warrants		$ 11.50
Sponsor [Member] \| Common Class B [Member] \| Founder Shares [Member]
Related Party Transaction [Line Items]
Related party transaction amounts of transaction			$ 25,000
Common stock, shares subscribed				5,031,250
Common stock, par value				$ 0.0001
Issuance of common stock to sponsor				$ 25,000
Sponsor [Member] \| Common Class A [Member] \| Share Price Equals or Exceeds $12.00 Per Share [Member] \| Founder Shares [Member]
Related Party Transaction [Line Items]
Share price	$ 12.00				$ 12.00
Common stock, transfers, threshold trading days	20 days
Common stock transfers restriction on number of days from the date of business combination	150 days
Common stock, transfers, threshold consecutive trading days	30 days

Commitments and Contingencies - Additional Information (Detail) - USD ($)		1 Months Ended
	Dec. 15, 2020	Sep. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Deferred underwriting fee payable	$ 6,900,000
Percentage of underwriting expense	1.00%
Underwriting commission reimbursement	$ 1,700,000
Advisory services fee		$ 10,000
Deferred success cost		$ 50,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Under writing discount per unit	$ 0.20
IPO [Member] \| Underwriting Expense [Member]
Subsidiary, Sale of Stock [Line Items]
Payments of stock issuance costs	$ 3,450,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Deferred underwriting commission per unit	$ 0.40

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	5 Months Ended
	Dec. 31, 2020	Dec. 15, 2020
Share price		$ 10.20
Event Triggering the Value of Warrants [Member]
Volume weighted average share price	$ 9.20
Number of consecutive trading days for determining share price	20 days
Public Warrants [Member]
Class of warrant or right redemption threshold consecutive trading days	30 days
Class of warrant or right, threshold period for exercise from date of closing public offering	12 months
Class of warrant, exercise price	$ 11.50
Class of warrants or rights term	5 years
Class of warrant or right outstanding	8,625,000
Private Placement Warrants [Member]
Class of warrant or right outstanding	7,175,000
Common Class A [Member]
Percentage of gross proceeds from share issue for the purposes of business combination	50.00%
Class of warrants or rights number of shares called by each warrant or right		1
Common Class A [Member] \| Share Price Equals or Exceeds $10.00 Per Share [Member]
Share price	$ 0.10
Percentage of warrants exercised on cashless basis	30.00%
Common Class A [Member] \| Share Price Equals or Exceeds $18.00 Per Share [Member]
Share price	$ 18.00
Common Class A [Member] \| Event Triggering the Value of Warrants [Member]
Share price	$ 9.20
Class of warrant or right adjustment to exercise price percentage.	115.00%
Common Class A [Member] \| Public Warrants [Member]
Class of warrant or right, threshold period for exercise from date of closing public offering	15 days
Number of consecutive tradings days for the purpose of determining the fair market value of common stock triggering warrant redemption	10 days
Class of warrants or rights number of shares called by each warrant or right	0.361
Common Class A [Member] \| Public Warrants [Member] \| Share Price Equals or Exceeds $10.00 Per Share [Member]
Share price	$ 10.00
Common Class A [Member] \| Public Warrants [Member] \| Share Price Equals or Exceeds $18.00 Per Share [Member]
Share price	18.00
Common Class A [Member] \| Public Warrants [Member] \| Share Trigger Price One [Member]
Share price that triggers warrant redemption	$ 10.00
Share price that triggers warrant redemption percentage	100.00%
Class of warrant or right, redemption price	$ 0.10
Number of days of notice to be given for the redemption of warrants	30 days
Common Class A [Member] \| Public Warrants [Member] \| Share Trigger Price Two [Member]
Share price that triggers warrant redemption	$ 18.00
Share price that triggers warrant redemption percentage	180.00%
Class of warrant or right, redemption price	$ 0.01
Number of days of notice to be given for the redemption of warrants	30 days
Warrant instrument redemption threshold consecutive trading days	20 days
Warrant instrument redemption threshold trading days	30 days
Period during which registration statement shall be effective for warrant redemption	30 days

Stockholder's Equity - Additional Information (Detail) - $ / shares	5 Months Ended
	Dec. 31, 2020	Dec. 15, 2020
Preferred stock, shares authorized	1,000,000
Preferred stock, shares outstanding	0
Common Class A [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	2,595,148
Common stock, shares outstanding	2,595,148
Common stock, threshold percentage on conversion of shares	20.00%
Common shares subject to redemption	14,654,852
Common stock shares outstanding subject to possible redemption	17,250,000
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	4,312,500
Common stock, shares outstanding	4,312,500
Common shares subject to redemption

Fair Value Measurements - Summary Of Fair Value, Measured On Recurring Basis (Detail)	Dec. 31, 2020 USD ($)
Fair Value, Inputs, Level 1 [Member]
Asset:
Investments held in Trust Account	$ 172,500,000
Liabilities:
Derivative warrant liabilities	0
Fair Value, Inputs, Level 2 [Member]
Asset:
Investments held in Trust Account	0
Liabilities:
Derivative warrant liabilities	0
Fair Value, Inputs, Level 3 [Member]
Asset:
Investments held in Trust Account	0
Liabilities:
Derivative warrant liabilities	$ 15,871,750

Fair Value Measurements - Summary Of Quantitative Information Regarding Fair Value Measurements (Detail) - Fair Value, Inputs, Level 3 [Member] - $ / shares		5 Months Ended
	Dec. 15, 2020	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price	$ 11.50	$ 11.50
Volatility	15.00%	15.00%
Stock price	$ 9.57	$ 9.98
Expected life of the options to convert	6 years 6 months 14 days	6 years 6 months
Risk-free rate	0.58%	0.58%
Dividend yield	0.00%	0.00%

Fair Value Measurements - Summary Of Change in Derivative Warrant Liabilities Measured At Fair Value (Detail)	5 Months Ended
	Dec. 31, 2020 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in fair value of derivative warrant liabilities	$ 2,355,500
Derivative warrant liabilities, Ending balance	15,871,750
Derivative Warrant Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities, Beginning balance	0
Issuance of Public and Private Warrants	13,516,250
Change in fair value of derivative warrant liabilities	2,355,500
Derivative warrant liabilities, Ending balance	$ 15,871,750

Fair Value Measurements - Additional Information (Detail)	5 Months Ended
	Dec. 31, 2020 USD ($)
Fair Value Disclosures [Abstract]
Fair value assets transfers	$ 0

Income Taxes - Schedule Of Components Of Income Tax Expense Benefit (Detail)	5 Months Ended
	Dec. 31, 2020 USD ($)
Current
Federal	$ 0
State	0
Deferred
Federal	(40,359)
State	0
Valuation allowance	40,359
Income tax provision	$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Income Taxes - Schedule Of Deferred Tax Assets and Liabilities (Detail)	Dec. 31, 2020 USD ($)
Deferred tax assets:
Net operating loss carryover	$ 17,537
Start-up/Organization costs	22,822
Total deferred tax assets	40,359
Valuation allowance	(40,359)
Deferred tax asset, net of allowance	$ 0

Income Taxes - Additional Information (Detail)	Dec. 31, 2020 USD ($)
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 0
Unrecognised tax benefit of accrued interest and penalties	$ 0

Income Taxes - Schedule Of Effective Income Tax Rate Reconciliation (Detail)	5 Months Ended
	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Statutory Federal income tax rate	21.00%
Financing cost - derivative warrant liabilities	(16.72%)
Change in fair value of derivative warrant liabilities	(2.92%)
Change in Valuation Allowance	(1.40%)
Income Taxes Benefit	0.00%